<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00919373</url>
  </required_header>
  <id_info>
    <org_study_id>T46</org_study_id>
    <nct_id>NCT00919373</nct_id>
  </id_info>
  <brief_title>Substrate Modification in Stable Ventricular Tachycardia in Addition to Implantable Cardioverter Defibrillator (ICD) Therapy</brief_title>
  <acronym>VTACH</acronym>
  <official_title>Substrate Modification in Stable Ventricular Tachycardia in Addition to ICD Therapy</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>St. Jude Medical</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>St. Jude Medical</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The main objective of this study is to compare the time from randomization to the first
      recurrence of any ventricular tachycardia (VT) in patients undergoing VT ablation (for stable
      VTs) and substrate ablation (for unstable VTs) after an initial episode of stable VT and
      patients not undergoing ablation, with both groups under the protection of an ICD.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The main objective of this study is to compare the time from randomization to the first
      recurrence of any VT in patients undergoing VT ablation (for stable VTs) and substrate
      ablation (for unstable VTs) after an initial episode of stable VT and patients not undergoing
      ablation, with both groups under the protection of an ICD.

      Prior to the ablation, the patients will undergo electrophysiologic study (EPS) with
      programmed ventricular stimulation, with the aim to reproduce the clinical VT. Most patients
      with coronary artery disease, systolic LV dysfunction, and one episode of clinical sustained
      VT have more than one inducible VT at electrophysiologic study. Since any inducible VT can
      become a potential clinical VT (24), an attempt will be made to ablate the clinical stable
      VT, as well as all inducible morphologies, stable or unstable.

      One of the following 2 ablation strategies will be possible for each VT:

        -  Substrate modification in sinus rhythm in case of unstable induced monomorphic VT which
           does not allow mapping and ablation in tachycardia, or noninducible stable clinical VT.

        -  VT ablation in tachycardia in case of stable VT

      For each procedure the number of tachycardias , the type of each tachycardia (inducible or
      noninducible, stable or unstable), the ablation strategy for each tachycardia (it is possible
      that lesions deployed for one tachycardia will render another tachycardia noninducible as
      well) and the procedural outcome for each tachycardia will be documented.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>July 2002</start_date>
  <completion_date type="Actual">January 2006</completion_date>
  <primary_completion_date type="Actual">January 2006</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>recurrence of any sustained clinical VT, stable or unstable, monomorphic or polymorphic, including VF, during the follow-up period</measure>
    <time_frame>2 years</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Severe clinical events (death, number of syncopes, number of hospital admissions for a cardiac indication, number of episodes of electrical storm (more than 3 VT episodes in 24 hours)) during the follow-up period .</measure>
    <time_frame>2 years</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Quality of life</measure>
    <time_frame>2 years</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of adequate ICD interventions (shocks and overdrive episodes caused by recurrence of VT or VF and not supraventricular arrhythmias or mechanical lead problems).</measure>
    <time_frame>2 years</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">110</enrollment>
  <condition>Ventricular Tachycardia</condition>
  <condition>Coronary Artery Disease</condition>
  <condition>Left Ventricular Dysfunction</condition>
  <arm_group>
    <arm_group_label>ICD-Implantation</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Implantation of an Implantable Cardioverter Defibrillator (ICD) alone.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>ICD + Ablation</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Stratified Catheter Ablation of Ventricular Tachycardia and ICD Implantation</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Substrate modification</intervention_name>
    <description>Catheter Ablation procedure - Substrate modification in sinus rhythm in case of unstable induced monomorphic Ventricular Tachycardia (VT) which does not allow mapping and ablation in tachycardia, or noninducible stable clinical VT.</description>
    <arm_group_label>ICD + Ablation</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>VT ablation</intervention_name>
    <description>Catheter Ablation of Ventricular Tachycardia (VT) in case of stable VT</description>
    <arm_group_label>ICD + Ablation</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>ICD Implantation</intervention_name>
    <description>Implantation of a marked released Implantable Cardioverter Defibrillator manufactured by St. Jude Medical</description>
    <arm_group_label>ICD-Implantation</arm_group_label>
    <arm_group_label>ICD + Ablation</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Coronary artery disease For the purpose of this study, coronary artery disease will be
             defined as the presence of a 50 % or more diameter stenosis of the left main coronary
             artery, or 75 % or more diameter stenosis of the left anterior descending, circumflex
             or right coronary arteries, or the history of a surgical or percutaneous
             revascularization procedure, or history of successful thrombolysis, or a history of
             prior myocardial infarction (e.g.: documented by Q-wave, R-reduction, aneurysm)

          -  Left ventricular ejection fraction ≤ 50 % as estimated by echocardiography or contrast
             ventriculography within the previous 30 days and evidence for old myocardial
             infarction (ECG, echocardiographic or venticulographic).

          -  One episode of documented stable clinical VT without any reversible causes

          -  Written informed consent

        Exclusion Criteria:

          -  Age &lt; 18 years or &gt; 80 year

          -  Protruding LV thrombus on pre-ablation echocardiogram

          -  Acute myocardial infarction within the preceding 1 months

          -  Class IV NYHA heart failure

          -  Valvular heart disease or mechanical heart valve precluding access to the left
             ventricle

          -  Unstable angina

          -  Cardiac surgery involving cardiotomy (not CABG) within the past 2 months

          -  Serum creatinine &gt; 220 mmol/L (2.5 mg/dL)

          -  Thrombocytopenia or coagulopathy

          -  Contraindication to heparin

          -  Pregnancy

          -  Acute illness or active systemic infection

          -  Other disease process likely to limit survival to less than 12 months

          -  Significant medical problem that in the opinion of the principal investigator would
             preclude enrollment in the study

          -  Participation in another investigational study

          -  Unwillingness to participate or lack of availability for follow-up

          -  Incessant VT or electrical storm

          -  Bundle branch reentry tachycardia as the presenting VT

          -  Preexisting ICD
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Karl-Heinz Kuck, Prof. Dr.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Asklepios Klinik St. Georg, Hamburg, Germany</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Institute for Clinical and Experimental Medicine</name>
      <address>
        <city>Prague</city>
        <zip>140 21</zip>
        <country>Czech Republic</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University Hospital of Aarhus</name>
      <address>
        <city>Aarhus</city>
        <zip>8200</zip>
        <country>Denmark</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Universitäts Medizin Mannheim</name>
      <address>
        <city>Mannheim</city>
        <state>Baden-Württemberg</state>
        <zip>68167</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Herz- und Gefäßklinik Bad Neustadt</name>
      <address>
        <city>Bad Neustadt</city>
        <state>Bavaria</state>
        <zip>97616</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Klinikum Großhadern der Ludwig-Maximilians-Universität München</name>
      <address>
        <city>München</city>
        <state>Bavaria</state>
        <zip>81377</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Kerckhoff Klinik GmbH</name>
      <address>
        <city>Bad Nauheim</city>
        <state>Hesse</state>
        <zip>61231</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Klinikum der Johann Wolfgang Goethe-Universität Frankfurt</name>
      <address>
        <city>Frankfurt</city>
        <state>Hesse</state>
        <zip>60596</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Medizinische Einrichtungen der Rheinischen Friedrich-Wilhelm-Universität</name>
      <address>
        <city>Bonn</city>
        <state>Northrhine-Westphalia</state>
        <zip>53127</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Universitätsklinikum Münster</name>
      <address>
        <city>Münster</city>
        <state>Northrhine-Westphalia</state>
        <zip>48149</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Helios Klinikum Wuppertal Klinikum Barmen</name>
      <address>
        <city>Wuppertal</city>
        <state>Northrhine-Westphalia</state>
        <zip>42283</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Klinikum der Stadt Ludwigshafen am Rhein gGmbH</name>
      <address>
        <city>Ludwigshafen</city>
        <state>Rhineland-Palatinate</state>
        <zip>67063</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Medizinische Fakultät der Universität Magdeburg</name>
      <address>
        <city>Magdeburg</city>
        <state>Saxony-Anhalt</state>
        <zip>39120</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Asklepios Klinik St. Georg</name>
      <address>
        <city>Hamburg</city>
        <zip>20099</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Universitäres Herzzentrum Hamburg</name>
      <address>
        <city>Hamburg</city>
        <zip>20246</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Klinikum der Ruprecht-Karls-Universität Heidelberg</name>
      <address>
        <city>Heidelberg</city>
        <zip>69120</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Universitätsspital Bern</name>
      <address>
        <city>Berne</city>
        <zip>3010</zip>
        <country>Switzerland</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Czech Republic</country>
    <country>Denmark</country>
    <country>Germany</country>
    <country>Switzerland</country>
  </location_countries>
  <results_reference>
    <citation>Kuck KH, Schaumann A, Eckardt L, Willems S, Ventura R, Delacrétaz E, Pitschner HF, Kautzner J, Schumacher B, Hansen PS; VTACH study group. Catheter ablation of stable ventricular tachycardia before defibrillator implantation in patients with coronary heart disease (VTACH): a multicentre randomised controlled trial. Lancet. 2010 Jan 2;375(9708):31-40. doi: 10.1016/S0140-6736(09)61755-4.</citation>
    <PMID>20109864</PMID>
  </results_reference>
  <verification_date>July 2013</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>June 10, 2009</study_first_submitted>
  <study_first_submitted_qc>June 11, 2009</study_first_submitted_qc>
  <study_first_posted type="Estimate">June 12, 2009</study_first_posted>
  <last_update_submitted>July 26, 2013</last_update_submitted>
  <last_update_submitted_qc>July 26, 2013</last_update_submitted_qc>
  <last_update_posted type="Estimate">July 29, 2013</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Catheter Ablation</keyword>
  <keyword>Defibrillators, Implantable</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Coronary Artery Disease</mesh_term>
    <mesh_term>Myocardial Ischemia</mesh_term>
    <mesh_term>Coronary Disease</mesh_term>
    <mesh_term>Tachycardia</mesh_term>
    <mesh_term>Ventricular Dysfunction</mesh_term>
    <mesh_term>Tachycardia, Ventricular</mesh_term>
    <mesh_term>Ventricular Dysfunction, Left</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

